Hippocratic AI builds in life sciences with Grove AI buy Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.

#HippocraticAI has expanded its focus with the #acquisition of #GroveAI, a specialist in AI used in #pharma R&D, to complement its current activities in patient-facing, generative AI (#GenAI) agents. #agenticAI

pharmaphorum.com/news/hippocr...

Fundraising 🇺🇸 Grove AI Secures $4.9 Million to Revolutionize Clinical Trials Grove AI, a clinical trial management firm, has secured $4.9 million in seed funding, led by venture firm A*. The investment will enhance its AI capabilities, aiming to reduce enrollment times and improve participant engagement in trials. This move reflects the rising interest in AI solutions in healthcare, emphasizing efficiency and integration.

1️⃣
Grove AI raises $4.9 million in seed funding:

Transforming clinical trial management with Agentic AI

Funding to scale team & improve product offerings

#GroveAI #ClinicalTrials #AgenticAI #SeedFunding